bbc medium
Funding Alert
homepage 3
 August 2, 2016                                                                                        
NIH and CDC SBIR Contract Solicitation Released
The NIH and CDC SBIR Contract Solicitation ( PHS 2017-1) has been released with a proposal deadline of 5 p.m. ET on October 21. As always, reading the full solicitation is strongly recommended!

Submission for all proposals is through the new Contract Proposal Submission (eCPS) website, No other method of proposal submission will be permitted.  A pre-proposal webinar on August 24 at 2 p.m. ET will discuss solicitation as well as details of electronic submission. Register for the webinar

Below is an at-a-glance list of topics included in the solicitation:

National Institutes of Health
National Cancer Institute (NCI)
355  Cell and Animal-Based Models to Advance Cancer Health Disparity Research
356  Tools and Technologies for Monitoring RNA
357  Innovative Tools for Interrogating Tumor Microenvironment Dynamics
358  Modulating the Microbiome to Improve Therapeutic Efficacy of Cancer Therapeutics
359  Technologies for Differential Isolation of Exosomes and Oncosomes
360  Manufacturing Innovation for the Production of Cell-Based Cancer Immunotherapies
361  Highly Innovative Tools for Quantifying Redox Effector Dynamics in Cancer
362  Informatics Tools to Measure Cancer Care Coordination
363  Connecting Cancer Caregivers to Care Teams: Digital Platforms to Support Informal Cancer             Caregiving
364  Methods/Software for Integration of Cancer Metabolomic Data with Other -Omic/ Imaging Data
365  Imaging Informatics Tools and Resources for Clinical Cancer Research
366  Clonogenic High-Throughput Assay for Screening Anti-Cancer Agents/ Radiation Modulators
367  Predictive Biomarkers to Improve Radiation Treatment.
368  Molecularly Targeted Radiation Therapy for Cancer Treatment
369  Development of Pediatric Cancer Drug Delivery Devices

National Center for Advancing Translational Sciences (NCATS)
015  Development of a Drone to be used in Laboratory Automation Projects

National Heart, Lung and Blood Institute (NHLBI)
098  Testing and Validation of Technologies for Inclusion in the CART Demonstration Project for                Collaborative Aging Research
099  Inhalational 5A Apolipoprotein A-I Mimetic Peptide for the Treatment of Asthma (SBIR-TT)
100  MRI Myocardial Needle Chemoablation Catheter
101  Membranous Ventricular Septal Defect (pmVSD) Transcatheter Occluder System
102  Transcatheter Occluder Device for Paravalvular Leaks

National Institute of Allergy and Infectious Diseases (NIAID)
040  Effective Targeted Delivery of RNA-based Vaccines and Therapeutics
041  Simplified Sequencing for TB Drug Resistance Testing
042  Qualitative HIV RNA Home Test
043  Adjuvant Development
044  Vaccine Adjuvant Screening and Discovery
045  Database Resources Integration
046  Rapid Point-of-Care Diagnostics to Detect Serologic Status of Individuals for Select Viral                     Infections
047  Development of Microbiome-based Products for Infectious Diseases
048  Non-Invasive Rapid Diagnostics for Respiratory Diseases in Children
049  Phage-based Diagnostic Platforms for Rapid Detection of Bacterial Pathogens

National Institute on Drug Abuse (NIDA)
161  Virtual Reality Tools to Enhance Evidence Based Treatment of Substance Use Disorders
162  Analytical Tools and Approaches for (Multidimensional) Scholarly Research Assessment and             Decision Support in the Biomedical Enterprise

Centers for Disease Control and Prevention (CDC)
National Center for Chronic Disease and Health Promotion (NCCDPHP)
038  Improve Contextual Awareness using Social Network Data

National Center for Emerging Zoonotic and Infectious Diseases (NCEZID)
014  Multiplexed Digital Counting of Single Molecules for Advanced Molecular Diagnosis

View the solicitation with full descriptions and contact information for each topic.
BBCetc is comprised of a group of geeks and gurus of commercialization and non-dilutive federal R&D funding for early-stage, technology companies.